Human T-lymphotropic virus 1

Human T-lymphotropic virus 1 (HTLV-1) is a retrovirus that infects T-lymphocytes, a type of white blood cell that plays a central role in the immune system. HTLV-1 is associated with several diseases, including adult T-cell leukemia/lymphoma (ATLL) and HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Virology[edit]
HTLV-1 is a member of the Deltaretrovirus genus within the Retroviridae family. The virus has a single-stranded RNA genome that is reverse transcribed into DNA and integrated into the host cell's genome. The viral genome encodes several proteins, including gag, pol, and env, which are essential for viral replication and assembly.
Transmission[edit]
HTLV-1 is transmitted through several routes:
- Mother-to-child transmission (primarily through breastfeeding)
- Sexual transmission
- Blood transfusion
- Intravenous drug use
Epidemiology[edit]
HTLV-1 is endemic in certain regions, including Japan, the Caribbean, parts of Africa, and South America. The prevalence of HTLV-1 infection varies widely, with some areas having infection rates as high as 10%.
Clinical Manifestations[edit]
HTLV-1 infection can lead to several clinical conditions:
- Adult T-cell leukemia/lymphoma (ATLL): A rare and aggressive form of cancer that affects T-lymphocytes.
- HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): A chronic and progressive disease of the spinal cord.
- Infective dermatitis: A chronic skin condition seen primarily in children.
Diagnosis[edit]
Diagnosis of HTLV-1 infection is typically made through serological testing to detect antibodies against the virus. Polymerase chain reaction (PCR) can also be used to detect viral DNA in infected cells.
Treatment[edit]
There is currently no cure for HTLV-1 infection. Treatment focuses on managing symptoms and complications. Antiretroviral therapy has limited efficacy in HTLV-1 infection, and treatment for ATLL may include chemotherapy and antiviral drugs.
Prevention[edit]
Preventive measures include:
- Screening of blood products for HTLV-1
- Encouraging safe sex practices
- Avoiding breastfeeding by HTLV-1 infected mothers
See Also[edit]
- Retrovirus
- Adult T-cell leukemia/lymphoma
- HTLV-1 associated myelopathy/tropical spastic paraparesis
- Infective dermatitis
- Serological testing
- Polymerase chain reaction
References[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
